Skip to main content
Springer Nature Link
Log in

Managing resistant Trichomonas vaginitis

  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Vaginal trichomoniasis is a sexually transmitted disease of worldwide importance that is commonly treated with metronidazole. Although surprisingly uncommon, resistance to metronidazole has nevertheless been widely reported. Patients with suspected resistant trichomoniasis should have the diagnosis confirmed either by visualization of motile trichomonads on saline microscopy or by culture. In addition, reinfection from a partner must be ruled out through a careful history. Data regarding treatment of metronidazole-resistant trichomoniasis are mainly limited to case reports or series. Most cases can be treated successfully with increasing doses of oral metronidazole. Other promising options include oral tinidazole and topical paromomycin cream.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

References and Recommended Reading

  1. Petrin D, Delgaty K, Bhait R, Garber G: Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 1998, 11:300–317. Very thorough basic science and clinical overview of infections caused by T. vaginalis.

    PubMed  CAS  Google Scholar 

  2. Lossick JG, Kent HL: Trichomoniasis: trends in diagnosis and management. Am J Obstet Gynecol 1991, 165:1217–1222.

    PubMed  CAS  Google Scholar 

  3. Cotch MF, Pastorek JG, Nugent RP, et al.: Vaginal Infections and Prematurity Study Group: demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women. Obstet Gynecol 1991, 78:1087–1092.

    PubMed  CAS  Google Scholar 

  4. Krieger JN, Tam MR, Stevens CE, et al.: Diagnosis of trichomoniasis: comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens. JAMA 1988, 259:1223–1238.

    Article  PubMed  CAS  Google Scholar 

  5. Pastorek JG, Cotch MF, Martin DH, Eschenbach DA: Vaginal Infections and Prematurity Study Group: clinical and microbiological correlates of vaginal trichomoniasis during pregnancy. Clin Infect Dis 1996, 23:1075–1080.

    PubMed  Google Scholar 

  6. Centers for Disease Control and Prevention: 1998 Guidelines for treatment of sexually transmitted diseases. MMWR 1998, 47:74–75. The latest Centers for Disease Control and Prevention recommendations for the management of trichomoniasis

    Google Scholar 

  7. Burtin P, Taddio A, Ariburnu O, et al.: Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 1995, 72:525–529.

    Article  Google Scholar 

  8. Krieger JN: Trichomoniasis in men: old issues and new data. Sex Transm Dis 1995, 22:83–96.

    Article  PubMed  CAS  Google Scholar 

  9. Krieger JN, Verdon M, Siegel N, Holmes KK: Natural history of urogenital trichomoniasis in men. J Urol 1993, 149:1455–1458.

    PubMed  CAS  Google Scholar 

  10. Müller M, Lossick JG, Gorrell TE: In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis. Sex Transm Dis 1988, 15:17–24.

    Article  PubMed  Google Scholar 

  11. Lossick JG, Müller M, Gorrell TE: In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis. J Infect Dis 1986, 153:948–955.

    PubMed  CAS  Google Scholar 

  12. Dombrowski MP, Sokol RJ, Brown WJ, Bronsteen RA:Intravenous therapy of metronidazole-resistant Trichomonas vaginalis. Obstet Gynecol 1987, 69:524–525.

    PubMed  CAS  Google Scholar 

  13. Dan M, Sobel JD: Trichomoniasis as seen in a chronic vaginitis clinic. Infect Dis Obstet Gynecol 1996, 4:77–84.

    Article  CAS  PubMed  Google Scholar 

  14. Houang ET, Ahmet Z, Lawrence AG: Successful treatment of four patients with recalcitrant vaginal trichomoniasis with a combination of zinc sulfate douche and metronidazole therapy. Sex Transm Dis 1997, 24:116–119.

    Article  PubMed  CAS  Google Scholar 

  15. Sears SD, O’Hare J: In vitro susceptibility of Trichomonas vaginalis to 50 antimicrobial agents. Antimicrob Agents Chemother 1988, 32:144–146.

    PubMed  CAS  Google Scholar 

  16. Pattman RS, Sprott MS, Kearns AM, Earnshaw M: Failure of mebendazole to cure trichomonal vaginitis resistant to metronidazole: case reports. Genitourin Med 1989, 65:274–275.

    PubMed  CAS  Google Scholar 

  17. Wong CA, Wilson PD, Chew TA: Povidone-iodine in the treatment of metronidazole-resistant Trichomonas vaginalis. Aust N Z J Obstet Gynaecol 1990, 30:169–171.

    PubMed  CAS  Google Scholar 

  18. Livengood CH III, Lossick JG: Resolution of resistant vaginal trichomoniasis associated with the use of intravaginal nonoxynol-9. Obstet Gynecol 1991, 78:954–956.

    PubMed  Google Scholar 

  19. British Co-Operative Clinical Group: An investigation, by questionnaire, of cases of recalcitrant vaginal trichomoniasis seen in genitourinary medicine clinics in the United Kingdom. Int J STD AIDS 1992, 3:24–27.

    Google Scholar 

  20. Voolman T, Boreham P: Metronidazole resistant Trichomonas vaginalis in Brisbane. Med J Aust 1993, 159:490.

    Google Scholar 

  21. Hamed KA, Studemeister AE: Successful response of metronidazole-resistant trichomonal vaginitis to tinidazole. Sex Transm Dis 1992, 19:339–340.

    Article  PubMed  CAS  Google Scholar 

  22. Nyirjesy P, Weitz MV, Gelone SP, Fekete T: Paromomycin for nitroimidazole-resistant trichomonosis. Lancet 1995, 346:1110.

    Article  PubMed  CAS  Google Scholar 

  23. Nyirjesy P, Sobel JD, Weitz MV, et al.: Difficult to treat trichomoniasis: results with paromomycin cream. Clin Infect Dis 1998, 26:986–988. Case series reviewing experience with paromomycin cream in cases in which metronidazole resistance or allergy was present

    PubMed  CAS  Google Scholar 

  24. Spitzbart H: Ist Paromomycin zur Behandlung der Trichomonaden-Infecktion bei der Frau geeignet? II: Klin Erfahrungen. Zentralbl Gynakol 1966, 88:563–566.

    PubMed  CAS  Google Scholar 

  25. Pearlman MD, Yashar C, Ernst S, Solomon W: An incremental dosing protocol for women with severe vaginal trichomoniasis and adverse reactions to metronidazole. Am J Obstet Gynecol 1996, 174:934–936.

    Article  PubMed  CAS  Google Scholar 

  26. Kurohara ML, Kwong FK, Lebherz TB, Klaustermeyer WB:Metronidazole hypersensitivity and oral desensitization. J Allergy Clin Immunol 1991, 88:279–280.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Temple University School of Medicine, 3401 North Broad Street, 19140, Philadelphia, PA, USA

    Paul Nyirjesy MD

Authors
  1. Paul Nyirjesy MD
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nyirjesy, P. Managing resistant Trichomonas vaginitis. Curr Infect Dis Rep 1, 389–392 (1999). https://doi.org/10.1007/s11908-999-0047-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-999-0047-x

Keywords